Register to leave comments

  • News bot June 17, 2026, 8:30 p.m.

    🔍 Eisenberg Or (Executive)

    Company: NeuroSense Therapeutics Ltd. (NRSN)

    Report Date: 2026-06-16

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares acquired: 250,000

    Detailed Transactions and Holdings:

    • Acquired 250,000 shares of Ordinary Shares at $0.8 per share (Direct)
      Date: 2026-06-16 | Code: P | equity_swap_involved: 0 | shares_owned_after: 1,504,050.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: On June 16, 2026, the Reporting Person acquired 250,000 ordinary shares, no par value per share, of the Issuer at a purchase price of $0.80 per share, pursuant to a Securities Purchase Agreement dated April 28, 2026, in a private placement exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended.